Neurogene (NGNE) Free Cash Flow (2013 - 2026)

Neurogene (NGNE) posted Free Cash Flow of -$26.4 million for Q1 2026, down 59.94% on a QoQ basis from -$16.5 million in Q4 2025, and down 22.39% year-over-year from -$34.0 million in Q1 2025.

Neurogene (NGNE) Free Cash Flow (2013 - 2026) Analysis & Trends

Neurogene's Free Cash Flow history runs 14 years deep, the most recent figure standing at -$26.4 million for Q1 2026.

  • Quarterly Free Cash Flow fell 22.39% year-over-year to -$26.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.1 million (down 15.45% YoY) and the FY2025 annual result came in at -$77.2 million, down 8.3% from the prior year.
  • Free Cash Flow was -$26.4 million for Q1 2026 at Neurogene, down from -$16.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$9.4 million in Q2 2023 and bottomed at -$26.4 million in Q1 2026.
  • A 5-year average of -$16.6 million and a median of -$16.5 million in 2025 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2023 — Free Cash Flow grew 20.69% — and 2024, when it sank 72.66%.
  • Neurogene's Free Cash Flow stood at -$19.3 million in 2022, then advanced by 11.63% to -$17.1 million in 2023, then fell by 2.45% to -$17.5 million in 2024, then gained by 5.85% to -$16.5 million in 2025, then slumped by 59.94% to -$26.4 million in 2026.
  • Business Quant data shows NGNE's Free Cash Flow at -$26.4 million in Q1 2026, -$16.5 million in Q4 2025, and -$19.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Neurogene 17.50 Mn 17.50 Mn - -26.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.38 Mn
Mar 31, 2026 -26.38 Mn
Dec 31, 2025 -16.49 Mn
Dec 31, 2025 -16.49 Mn
Sep 30, 2025 -19.63 Mn
Sep 30, 2025 -19.63 Mn
Jun 30, 2025 -19.57 Mn
Jun 30, 2025 -19.57 Mn
Mar 31, 2025 -21.55 Mn
Mar 31, 2025 -21.55 Mn
Dec 31, 2024 -17.52 Mn
Dec 31, 2024 -17.52 Mn
Sep 30, 2024 -15.74 Mn
Sep 30, 2024 -15.74 Mn
Jun 30, 2024 -16.28 Mn
Jun 30, 2024 -16.28 Mn
Mar 31, 2024 -21.79 Mn
Mar 31, 2024 -21.79 Mn
Dec 31, 2023 -17.10 Mn
Dec 31, 2023 -17.10 Mn